Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qurevo and Ribavirin in Chronic Hepatitis C Patients on Hemodialysis
NCT03067883Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Nov 2016
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
A Phase 2 trial of ombitasvir + paritaprevir + ritonavir in hepatitis C (HCV), sponsored by Ain Shams University. Status: unknown.
02
Drugs
ombitasvir + paritaprevir + ritonavir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03067883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067883.